Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

BACKGROUND: COVID-19 is a respiratory disease that results in a prothrombotic state manifesting as thrombotic, microthrombotic and thromboembolic events. As a result, several antithrombotic modalities have been implicated in the treatment of this disease. This study aimed to identify if therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Matli, Kamal, Chamoun, Nibal, Fares, Aya, Zibara, Victor, Al-Osta, Soad, Nasrallah, Rabih, Salameh, Pascale, Mokhbat, Jacques, Ghanem, Georges
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Special Populations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493601/
https://www.ncbi.nlm.nih.gov/pubmed/34611018
http://dx.doi.org/10.1136/openhrt-2021-001785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493601/
https://www.ncbi.nlm.nih.gov/pubmed/34611018
http://dx.doi.org/10.1136/openhrt-2021-001785

Ejemplares similares